|
Market Closed -
Other stock markets
|
Pre-market 09:28:00 pm | |||
| 390.33 USD | -8.54% |
|
395.09 | +1.22% |
Company Valuation: Elevance Health, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 112,508 | 122,511 | 110,797 | 85,556 | 77,906 | 84,765 | - | - |
| Change | - | 8.89% | -9.56% | -22.78% | -8.94% | 8.8% | - | - |
| Enterprise Value (EV) 1 | 130,384 | 139,238 | 129,391 | 108,500 | 100,461 | 108,871 | 107,546 | 106,776 |
| Change | - | 6.79% | -7.07% | -16.15% | -7.41% | 8.37% | -1.22% | -0.72% |
| P/E | 18.7x | 20.7x | 18.7x | 14.4x | 13.9x | 19.3x | 14.4x | 12.1x |
| PBR | 3.17x | 3.36x | 2.85x | 2.08x | 1.79x | 1.89x | 1.7x | 1.52x |
| PEG | - | 63.99x | 11.32x | 7.89x | -7.59x | -1x | 0.4x | 0.7x |
| Capitalization / Revenue | 0.82x | 0.79x | 0.65x | 0.49x | 0.39x | 0.43x | 0.42x | 0.4x |
| EV / Revenue | 0.95x | 0.89x | 0.76x | 0.62x | 0.51x | 0.56x | 0.54x | 0.5x |
| EV / EBITDA | 13x | 12.7x | 10.7x | 8.9x | 9.5x | 10.4x | 10.1x | 9.43x |
| EV / EBIT | 14.2x | 13.9x | 11.5x | 9.54x | 10.4x | 12.3x | 11.4x | 9.88x |
| EV / FCF | 17.9x | 19.2x | 19.1x | 23.8x | 31.7x | 21.5x | 17.7x | 15.5x |
| FCF Yield | 5.58% | 5.2% | 5.23% | 4.2% | 3.16% | 4.66% | 5.66% | 6.45% |
| Dividend per Share 2 | 4.52 | 5.12 | 5.92 | 6.52 | 6.84 | 6.922 | 7.291 | 7.771 |
| Rate of return | 0.98% | 1% | 1.26% | 1.77% | 1.95% | 1.77% | 1.87% | 1.99% |
| EPS 2 | 24.73 | 24.81 | 25.22 | 25.68 | 25.21 | 20.27 | 27.12 | 32.16 |
| Distribution rate | 18.3% | 20.6% | 23.5% | 25.4% | 27.1% | 34.1% | 26.9% | 24.2% |
| Net sales 1 | 136,943 | 155,660 | 170,209 | 175,204 | 197,584 | 195,770 | 200,109 | 211,440 |
| EBITDA 1 | 10,011 | 10,924 | 12,114 | 12,191 | 10,574 | 10,432 | 10,646 | 11,325 |
| EBIT 1 | 9,150 | 10,016 | 11,254 | 11,378 | 9,656 | 8,836 | 9,394 | 10,807 |
| Net income 1 | 6,104 | 6,025 | 5,987 | 5,980 | 5,662 | 4,479 | 5,840 | 6,649 |
| Net Debt 1 | 17,876 | 16,727 | 18,594 | 22,944 | 22,555 | 24,106 | 22,781 | 22,011 |
| Reference price 2 | 463.54 | 512.97 | 471.56 | 368.90 | 350.55 | 390.33 | 390.33 | 390.33 |
| Nbr of stocks (in thousands) | 242,715 | 238,828 | 234,959 | 231,923 | 222,239 | 217,162 | - | - |
| Announcement Date | 26/1/22 | 25/1/23 | 24/1/24 | 23/1/25 | 28/1/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 19.74x | 0.56x | 10.22x | 1.78% | 84.76B | ||
| 24.31x | 0.96x | 14.99x | 2.12% | 380B | ||
| 11.93x | 0.34x | 7.3x | 2.07% | 78.78B | ||
| 48.68x | 0.36x | 20.7x | 0.87% | 48.96B | ||
| 26.85x | 0.15x | 14.26x | -.--% | 32.89B | ||
| 70.18x | 0.24x | 15.88x | -.--% | 12.16B | ||
| 109.4x | 0.75x | 25.13x | -.--% | 4.33B | ||
| 356.44x | 0.79x | 39.45x | -.--% | 2.46B | ||
| 25.08x | 1.71x | 9.89x | -.--% | 2.53B | ||
| 48.09x | 2.7x | 14.24x | 0.58% | 276M | ||
| Average | 74.07x | 0.86x | 17.21x | 0.74% | 64.72B | |
| Weighted average by Cap. | 26.89x | 0.74x | 13.98x | 1.79% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ELV Stock
- Valuation Elevance Health, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















